J. Rymer, R. Wilson, and K. Ballard, Making decisions about hormone replacement therapy, BMJ, vol.326, issue.7384, pp.322-326, 2003.
DOI : 10.1136/bmj.326.7384.322

J. Rossouw, G. Anderson, R. Prentice, A. Lacroix, C. Kooperberg et al., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial, Jama, vol.288, pp.321-333, 2002.

G. Anderson, M. Limacher, A. Assaf, T. Bassford, S. Beresford et al., study in healthy postmenopausal women, J Thromb Haemost, vol.1, pp.1984-1991, 2003.

M. Post, M. Christella, L. Thomassen, M. Van-der-mooren, W. Van-baal et al., Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: A randomized, placebo-controlled study in postmenopausal women. Arteriosclerosis, thrombosis, and vascular biology, pp.1116-1121, 2003.

M. Post, M. Van-der-mooren, W. Van-baal, M. Blankenstein, H. Merkus et al., Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: A randomized placebo-controlled study, American Journal of Obstetrics and Gynecology, vol.189, issue.5, pp.1221-1227, 2003.
DOI : 10.1067/S0002-9378(03)00599-4

C. Borgfeldt, C. Li, and G. Samsioe, Low-dose oral combination of 17??-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1, Climacteric, vol.27, issue.16, pp.78-85, 2004.
DOI : 10.1016/S0029-7844(96)00530-3

J. Stevenson, A. Oladipo, N. Manassiev, M. Whitehead, S. Guilford et al., Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers, British Journal of Haematology, vol.2, issue.3, pp.802-808, 2004.
DOI : 10.1016/S0925-4439(97)00097-5

C. Martinez, L. Basurto, A. Zarate, R. Saucedo, E. Gaminio et al., Transdermal estradiol does not impair hemostatic biomarkers in postmenopausal women, Maturitas, vol.50, issue.1, pp.39-43, 2005.
DOI : 10.1016/j.maturitas.2004.03.011

M. Osmanagaoglu, S. Osmanagaoglu, T. Osmanagaoglu, B. Okumus, and H. Bozkaya, Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women, Fertility and Sterility, vol.84, issue.2, pp.384-393, 2005.
DOI : 10.1016/j.fertnstert.2005.01.131

P. Collins, M. Flather, B. Lees, R. Mister, A. Proudler et al., Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study, European Heart Journal, vol.27, issue.17, pp.2046-2053, 2006.
DOI : 10.1093/eurheartj/ehl183

B. Zegura, B. Guzic-salobir, M. Sebestjen, and I. Keber, The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women, Menopause, vol.13, pp.643-650, 2006.

C. Kooperberg, M. Cushman, J. Hsia, J. Robinson, A. Aragaki et al., Can biomarkers identify women at increased stroke risk? The women's health initiative hormone trials Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy Archives of internal medicine, PLoS clinical trials, vol.2168, pp.28-462245, 2007.

G. Perrone, O. Capri, P. Galoppi, R. Brunelli, E. Bevilacqua et al., Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory Hormones and haemostasis Revised version v_1_acc 18 /19 factors and lipoprotein(a) in menopause. Gynecologic and obstetric investigation, pp.33-39, 2009.

A. Rousseau, A. Robert, G. Gerotziafas, D. Torchin, F. Zannad et al., Effect of two oral doses of 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: A randomized double-blind placebo-controlled study, Fundamental & clinical pharmacology, vol.24, pp.239-245, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00683334

J. Rossouw, K. Johnson, M. Pettinger, M. Cushman, P. Sandset et al., Tissue factor pathway inhibitor, activated protein c resistance, and risk of ischemic stroke due to postmenopausal hormone therapy. Stroke; a journal of cerebral circulation, pp.952-957, 2012.

A. Hillarp, B. Zoller, P. Svensson, and B. Dahlback, The 20210 a allele of the prothrombin gene is a common risk factor among swedish outpatients with verified deep venous thrombosis, Thromb Haemost, vol.78, pp.990-992, 1997.

N. Mackman, R. Tilley, and N. Key, Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arteriosclerosis, thrombosis, and vascular biology, pp.1687-1693, 2007.

R. Macfarlane, An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier, Nature, vol.9, issue.4931, pp.498-499, 1964.
DOI : 10.1038/202498a0

E. Davie and O. Ratnoff, Waterfall Sequence for Intrinsic Blood Clotting, Science, vol.145, issue.3638, pp.1310-1312, 1964.
DOI : 10.1126/science.145.3638.1310

A. Kumar, S. Kar, and W. Fay, Thrombosis, physical activity, and acute coronary syndromes, Journal of Applied Physiology, vol.111, issue.2, pp.599-605, 2011.
DOI : 10.1152/japplphysiol.00017.2011

J. Miller, B. Chan, and H. Nelson, Postmenopausal Estrogen Replacement and Risk for Venous Thromboembolism, Annals of Internal Medicine, vol.136, issue.9, pp.680-690, 2002.
DOI : 10.7326/0003-4819-136-9-200205070-00011

E. Castoldi and J. Rosing, Thrombin generation tests. Thrombosis research, pp.21-25, 2011.

L. Basurto, R. Saucedo, A. Zarate, C. Martinez, E. Gaminio et al., Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women Gynecologic and obstetric investigation, pp.61-64, 2006.

P. Koninckx and D. Spielmann, A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women, Gynecol Endocrinol, vol.21, pp.82-89, 2005.

B. Pornel and D. Spielmann, A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1 mg 17beta- estradiol and trimegestone compared with a regimen containing 1 mg estradiol valerate and norethisterone over a two-year period, Gynecol Endocrinol, vol.21, pp.74-81, 2005.

P. Scarabin, H. Hemker, C. Clement, V. Soisson, and M. Alhenc-gelas, Increased thrombin generation among postmenopausal women using